Eurocine Vaccines Expects Clinical Results June/July 2017

STOCKHOLM, Apr. 06, 2017 /PRNewswire/ --

Eurocine Vaccines expects results from the ongoing immunological analyses in June/July 2017. The samples presently being analyzed were collected during the clinical study on the nasal influenza vaccine candidate Immunose™ FLU, conducted in the current influenza season, 2016/2017.

"I am pleased that the progress of the immunological analyses has been somewhat faster than expected", said CSO Dr. Anna-Karin Maltais."

CONTACT:

CEO of Eurocine Vaccines AB

[email protected] 

+46-70-634-0171

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/eurocine-vaccines/r/eurocine-vaccines-expects-clinical-results-june-july-2017,c2234148

The following files are available for download:

SOURCE Eurocine Vaccines